September 29 - October 2, 2004; Seattle, WA
Topics to be covered include promising new targets for male contraception (affecting spermatogenesis, differentiation, maturation, motility, capacitation and binding), clinical trials, hormonal male contraception, public-private partnerships and regulatory guidelines for contraceptive development, translational research from target identification to clinical application and recommendations for future research.